202 related articles for article (PubMed ID: 18630357)
1. Donepezil: syncope. Various cardiac disorders.
Prescrire Int; 2008 Jun; 17(95):113. PubMed ID: 18630357
[No Abstract] [Full Text] [Related]
2. Donepezil and cardiac syncope: case report.
Jane Newby V; Anne Kenny R; McKeith IG
Int J Geriatr Psychiatry; 2004 Nov; 19(11):1110-2. PubMed ID: 15497193
[No Abstract] [Full Text] [Related]
3. Behavioral complications associated with donepezil.
Wengel SP; Roccaforte WH; Burke WJ; Bayer BL; McNeilly DP; Knop D
Am J Psychiatry; 1998 Nov; 155(11):1632-3. PubMed ID: 9812142
[No Abstract] [Full Text] [Related]
4. Questions about donepezil.
Elie LM; Cole MG
CMAJ; 1998 Apr; 158(8):1014-5. PubMed ID: 9580729
[No Abstract] [Full Text] [Related]
5. [Many Alzheimer patients untreated].
MMW Fortschr Med; 2002 Oct; 144(40):51. PubMed ID: 12449096
[No Abstract] [Full Text] [Related]
6. Alcohol abuse in an elderly woman taking donepezil for Alzheimer disease.
Marinho V; Laks J; Engelhardt E; Conn D
J Clin Psychopharmacol; 2006 Dec; 26(6):683-5. PubMed ID: 17110839
[No Abstract] [Full Text] [Related]
7. Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.
Bordier P; Garrigue S; Barold SS; Bressolles N; Lanusse S; Clémenty J
Europace; 2003 Oct; 5(4):429-31. PubMed ID: 14753643
[TBL] [Abstract][Full Text] [Related]
8. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study.
Prasher VP; Adams C; Holder R;
Int J Geriatr Psychiatry; 2003 Jun; 18(6):549-51. PubMed ID: 12789681
[No Abstract] [Full Text] [Related]
9. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
[No Abstract] [Full Text] [Related]
10. [Acetylcholinesterase inhibitor. Helpful not just in Alzheimer dementia].
MMW Fortschr Med; 2002 Aug; 144(33-34):59. PubMed ID: 12380156
[No Abstract] [Full Text] [Related]
11. Abnormal movements with donepezil in Alzheimer disease.
Amouyal-Barkate K; Bagheri-Charabiani H; Montastruc JL; Moulias S; Vellas B
Ann Pharmacother; 2000 Nov; 34(11):1347. PubMed ID: 11098352
[No Abstract] [Full Text] [Related]
12. [Post-marketing observational study of donepezil].
Ibach B
Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820
[No Abstract] [Full Text] [Related]
13. Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease.
Starr JM
J Am Geriatr Soc; 2007 May; 55(5):800-1. PubMed ID: 17493206
[No Abstract] [Full Text] [Related]
14. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
[TBL] [Abstract][Full Text] [Related]
15. Anti-Alzheimer drugs: life-threatening adverse effects.
Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17326275
[TBL] [Abstract][Full Text] [Related]
16. Pisa syndrome due to a cholinesterase inhibitor (donepezil): a case report.
Miyaoka T; Seno H; Yamamori C; Inagaki T; Itoga M; Tsubouchi K; Horiguchi J
J Clin Psychiatry; 2001 Jul; 62(7):573-4. PubMed ID: 11488374
[No Abstract] [Full Text] [Related]
17. Donepezil for Alzheimer's disease.
Benjamin B; Burns A
Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
[TBL] [Abstract][Full Text] [Related]
18. Donepezil for severe Alzheimer's disease.
Opie LH
Lancet; 2006 Jul; 368(9533):361-2; author reply 362. PubMed ID: 16876651
[No Abstract] [Full Text] [Related]
19. Case report: Post-traumatic memories triggered by donepezil in a dose-dependent pattern.
Wolff ML
Am J Geriatr Pharmacother; 2012 Jun; 10(3):219-22. PubMed ID: 22445625
[TBL] [Abstract][Full Text] [Related]
20. Violent behavior-associated with donepezil.
Bouman WP; Pinner G
Am J Psychiatry; 1998 Nov; 155(11):1626-7. PubMed ID: 9812132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
